Q32 Bio names José Trevejo chief medical officer — SkimNews
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Q32 Bio hired José Trevejo as chief medical officer in a move highlighted by STAT+'s weekly comings-and-goings column.
- José Trevejo previously served as chief medical officer and head of clinical pipeline strategy at Enveda Therapeutics before joining Q32 Bio.
Why it matters: Q32 Bio is filling its top clinical role with a candidate who already held the CMO seat at another company and ran its clinical pipeline strategy — a direct, hands-on operator rather than a first-time CMO hire.
Ask SkimNews